Abiopharma

🔍 Carter Thomas L Jr (Director)

Company: Black Stone Minerals, L.P. (BSM)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 23,604 shares of Common units representing limited partner interests at $13.3186 per share (Direct)
  Date: 2026-05-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,637,450.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 25,000 shares of Common units representing limited partner interests at $13.4742 per share (Direct)
  Date: 2026-05-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,662,450.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 19,154 shares of Common units representing limited partner interests at $13.4754 per share (Direct)
  Date: 2026-05-12 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,681,604.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $13.29 to $13.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units purchased at each separate price within the ranges set forth in this footnote.
• F2: The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $13.44 to 13.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units sold at each separate price within the ranges set forth in this footnote.
• F3: The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $13.42 to $13.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units purchased at each separate price within the ranges set forth in this footnote.